PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS INCLUDING IL-31 ANTAGONIST AS AN ACTIVE INGREDIENT Russian patent published in 2023 - IPC A61K39/395 A61K45/00 A61P17/00 A61P17/04 

FIELD: medicine; allergology; dermatology.

SUBSTANCE: group of inventions discloses a method of treatment of atopic dermatitis including the administration of an IL-31 antagonist several times in equal quantities at equal intervals between the doses to a subject suffering from atopic dermatitis or predisposed to its development, at a dose of 25 to 100 mg/body/4 weeks, where atopic dermatitis is moderate to severe atopic dermatitis and topical therapy is insufficiently effective or intolerable (options).

EFFECT: use of a group of inventions ensures an increase in the effectiveness of the treatment regimen, the results of which cannot be achieved using standard therapeutic methods of treating atopic dermatitis.

12 cl, 4 tbl, 11 dwg, 6 ex